CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 19 No. 12
Pages: 1  2  
Next
Focus On Colon Cancer 

Long Constitutional Telomere Length May Serve as Measure for Colon Cancer Risk in Younger Patients

By Shalmali Pal | December 30, 2010

DNA strips that protect chromosome tips during cell division are influenced by aging, health status, and environmental factors.

Like the protective plastic cap at the ends of shoelaces that prevent them from unraveling, telomeres protect the ends of chromosomes. These small strips of DNA prevent chromosome tips from fraying during cell division. But as the cells divide, the telomeres shorten and the cells age. Shortened telomeres have been linked to an increased risk of cancer development. Researchers at the Mayo Clinic in Rochester, Minn., wanted to see if telomere shortening was linked to colon cancer development at a younger age.

“When we look at colorectal cancer, it’s typically a disease of the aging,” said lead investigator Lisa A. Boardman, MD, an associate professor of medicine. “In young-onset colon cancer, could telomere length relate to cancer? Are these patients biologically older based on their telomere length?”

Dr. Boardman’s group measured blood leukocyte DNA telomere length with quantitative polymerase chain reaction (PCR) in 772 people diagnosed with microsatellite stable colorectal cancer. The patients had been diagnosed at less than 60 years and had no history of chemoradiotherapy. These subjects’ telomere lengths were compared with telomere lengths from 1,660 nonrelated, healthy controls (2010 AACR Colorectal Cancer: Biology to Therapy abstract A26).

“We anticipated that we would see some people who had young-onset colon cancer and shorter telomeres compared to people of the same age group who did not have cancer,” Dr. Boardman said.


Anil Rustgi, MD

Instead, the researchers found that in people under age 50, a longer telomere length correlated with a higher colorectal cancer risk. “If you were under the age of 50 and you had the longest telomere length, compared with the middle range, the odds in favor of developing colon cancer was 30%,” Dr. Boardman said. The reverse was true for people over 50, with a longer telomere lowering the cancer risk while a shorter telomere was associated with a 22% increased risk for cancer.

The group also found that the odds ratio (OR) for colorectal cancer in individuals with the shortest and longest telomere lengths was 1.14 (P = .01).

This OR remained high after adjusting for various environmental factors, such as fruit, vegetable, and red meat intake; folic acid(Drug information on folic acid) intake; and comorbidity of diabetes mellitus, Dr. Boardman’s group said.

    “In young-onset colon cancer, could telomere length relate to cancer? Are these patients biologically older based on their telomere length?”
—Lisa A. Boardman, md

 

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by DR Dave | December 31, 2010 6:00 PM EST

Some things seems a bit awry here and perhaps they are the result of this article and not the study but: First what was the cell line being tested? And 2nd Maybe its me but last time I checked Q-PCR varied by as much as 1000 base pairs per test, Is this the best choice to publish an article that flies in the face of every single thing we know about telomere length/ Might Flo-Fish or better yet short telomere testing form Maria Blasco's lab been a better choice here especially given the nature of the findings?






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy